We equip expert clinicians with cutting edge technology and make them available directly to men who want testing. We focus on doing one thing exceptionally well, all to make sure no man gets told that he has been diagnosed late. We learn from data and the latest in clinical research to deliver world-class service. Having collated the largest database in the world (250,000 men and counting) we have generated some of the world’s most powerful algorithms to help us detect prostate cancer early.
PSA-based machine learning model improves prostate cancer risk stratification in a screening population (National Library of Medicine)
PSA-based machine learning model improves prostate cancer risk stratification in a screening population (SpringerLink)
Metabolic deregulation in prostate cancer
Dr. Elliot Smith is one of the leading voices of Artificial Intelligence for healthcare in the world. After completing his PhD at the University of Queensland – Elliot founded Maxwell Plus after seeing huge issues with the rates of early and accurate detection. He has published numerous papers across the use of Artificial Intelligence in healthcare and is the supervisor of a number of PhD students studying Artificial Intelligence applications to imaging of the brain and body.
Dr. Peter Swindle is one of Australia’s leading Urologists having worked solely in prostate cancer for many years. He has treated thousands of patients and conducted thousands of robotic prostatectomys across the country. Dr. Swindle is passionate about early and accurate detection and has been heavily involved in the advocacy of early testing and the use of multi-parametric MRI.
Phil is a Partner at the CSIRO’s venture capital fund – Main Sequence Ventures. He invests in deep tech founders who are building unimaginable new companies with a strong connection to research. Before this, he was the founder of Australia’s first Silicon Valley-style incubator, Pollenizer, where Phil played an instrumental role in developing the startup ecosystem across the Asia Pacific and advised some of the world’s biggest organisations on practical ways to deliver new growth and the cultural change that is required to get there.
Tom is responsible for ensuring Maxwell Plus’ patients get the accurate, fast and high-quality care they need. Before Maxwell Plus – Tom was an engineer and management consultant with McKinsey & Company gaining experience across a number of industries in strategic development, operations improvements and transaction advisory. He was a co-founder of a medical device startup at University that successfully completed a number of medical trials.
Anthony (Tony) Costello, AM MD FRACS FRCSI Hon MB BS is an Australia trained Urologist formerly head of the Department of Urology, Royal Melbourne Hospital (1999 – 2020) and remains Professorial Fellow in the University of Melbourne Department of Surgery. Professor Costello has published over 250 peer reviewed articles in various journals internationally and nationally. He is the author of a 20 chapters in textbooks internationally. In 2007 he established a Bio resource: tissue bank for prostate cancer tissue, blood, and bio informatics. Professor Costello was awarded the Medal of the Order of Australia AM for outstanding service in medical research and education. In 2012 he was integral in establishing the Australian Prostate Centre (APC). APC established and built a dedicated Centre for prostate cancer patients and has now seen 16,000 patients. The centre is a significant research resource in prostate cancer.